Atlas Venture Life Science Advisors, LLC
Q3 2025 13F-HR Holdings
Net value change ($000)
+90,282
(13.6%)
New positions
1
Sold out positions
3
Turnover %
15.0%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q2 2025
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| KYMR | 63,458 | 29.7% |
| SION | 42,242 | 65.9% |
| KRRO | 40,255 | 283.4% |
| DYN | 28,578 | 32.9% |
| IRON | 15,303 | 12.1% |
| DAWN | 3,536 | 8.5% |
| IMA | 3,079 | NEW |
| GBIO | 2,417 | 91.2% |
| QTTB | 1,025 | 32.9% |
Top Reduces (Value $000, Stocks/ETFs)
| Third Harmonic Bio, Inc. | -56,484 | -100.0% |
| Vigil Neuroscience, Inc. | -46,403 | -100.0% |
| IMA | -6,724 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|